Atrium Therapeutics
RNA
#4336
Rank
โ‚ฌ2.10 B
Marketcap
13,34ย โ‚ฌ
Share price
-6.47%
Change (1 day)
-51.29%
Change (1 year)

Revenue for Atrium Therapeutics (RNA)

Revenue in 2025 (TTM): โ‚ฌ3.58 Million

According to Atrium Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ16.04 Million. an increase over the revenue in the year 2024 that were of โ‚ฌ9.39 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Atrium Therapeutics from 2023 to 2025

Annual revenue

Year Revenue Change
2025 โ‚ฌ16.04 M70.85%
2024 โ‚ฌ9.39 M11.6%
2023โ‚ฌ8.41 M